Language: BG BG
← Back to results
Active (not recruiting) Not applicable NCT06887920

Comparison of MiSight 1-Day and Acuvue Oasys for Presbyopia in Myopic Children

No applicable phase (e.g. observational)
Conditions: Myopia Progressing

Sponsor: Pauline Kang

trial.available_in: БГ
Overview
This study will compare the effects on myopia progression over the course of one year for eyes wearing MiSight 1 Day contact lenses compared to ACUVUE OASYS for PRESBYOPIA contact lenses.
Who can participate
Inclusion Criteria: 1. Aged 6-12 years (inclusive) 2. Is willing to wear soft contact lenses daily 3. Spherical equivalent myopic refractive error between -0.50 to -5.00 D in each eye and astigmatism \< 1.00 D 4. Best corrected logMAR visual acuity of 0.1 or better in both eyes 5. Good ocular and general health 6. No previous use of myopia control interventions for more than 1 month or within the last 30 days 7. Competent enough in English to be able to fully understand the participant information and consent form Exclusion Criteria: 1. Strabismus at distance or near, amblyopia or significant anisometropia (\>1D) 2. Systemic or ocular conditions that may affect contact lens use (e.g., allergy) or that may affect refractive development (e.g., ptosis) 3. Previous history of ocular surgery, trauma, or chronic ocular disease 4. Contraindications to contact lens use 5. Ocular or systemic medication use which may interfere or interact with contact lens wear or ocular development 6. Plans to migrate or move during the study 7. Child, parents or guardians not willing to comply with treatment and/or follow-up schedule
Locations 1
Australia (1)
University of New South Wales
Sydney , New South Wales
Technical details
Status
Active (not recruiting)
Phase
Not applicable
Study type
INTERVENTIONAL
Sex
Male and female
Minimum age
6 Years
Maximum age
12 Years
Healthy volunteers
No
Start date
11.02.2021
Completion date
01.12.2025
Registry ID
NCT06887920
Source
anzctr
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.